Back to RCM
CancerIQ
CancerIQ is a Chicago-based precision health software company whose EHR-integrated platform automates hereditary cancer risk assessment, genetic testing workflows, and screening follow-up for health systems. It is deployed across 40+ health systems and 200+ clinical sites, with a telehealth genetic counseling network attached.
Why interesting to a deal team
Chicago healthcare SaaS with recurring health-system revenue and a sponsor-ready growth-equity profile. Grant Chamberlain ran Ziegler's exclusive placement for the $14M Series B, giving direct access to management, the cap table (Merck GHI, Amgen Ventures, McKesson Ventures, OSF), and diligence-grade knowledge of the capital-raise process.
Experts connected to this company
Sources
- Page titlePrimarycanceriq.com
- Page titleOtherprweb.com/releases/ziegler-advises-canceriq-on-series-b-private-placement-led-by-merck-and-amgen-888631828.html
Strongest evidencePage title2 public sourcesHow the grades work